Impact BioMedical (IBO) vs Incannex Healthcare (IXHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Impact BioMedical (IBO) has outperformed Incannex Healthcare (IXHL) over the past year, losing 42.7% versus a loss of 75.8%. Incannex Healthcare is the larger company by market cap ($39.5 million vs $35.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IBO | IXHL |
|---|---|---|
| Share price | $4.18 | $3.15 |
| Market cap | $35.71M | $39.52M |
| 1-day change | -6.70% | -0.94% |
| YTD return | -29.92% | -70.39% |
| 1-year return | -42.73% | -75.80% |
| P/E ratio (TTM) | 0.38 | — |
| EPS (TTM) | $11.11 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.51 | $14.91 |
| 52-week low | $4.10 | $2.49 |
| Distance from 52-week high | -60.21% | -78.87% |
| Average volume | 11.61K | 98.82K |
| Shares outstanding | 8.54M | 12.54M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IBO has outperformed IXHL by 33.1 percentage points over the past year.
IBO vs IXHL FAQ
Which is bigger, Impact BioMedical or Incannex Healthcare?
Incannex Healthcare (IXHL) is larger, with a market capitalization of $39.52M compared with $35.71M for Impact BioMedical (IBO).
Which stock has performed better over the past year, IBO or IXHL?
IBO returned -42.73% over the past 12 months, compared with -75.80% for IXHL (price return, excluding dividends). Past performance does not predict future results.
Are Impact BioMedical and Incannex Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.